Vince Anzalone | VP, IR |
Christopher Anzalone | President and CEO |
Javier San Martin | Chief Medical Officer |
Ken Myszkowski | CFO |
James Hamilton | SVP, Discovery and Translational Medicine |
Luca Issi | RBC Capital |
Alethia Young | Cantor |
Maury Raycroft | Jefferies |
Esther Rajavelu | UBS |
Joel Beatty | Baird |
Patrick Trucchio | H.C. Wainwright |
Mani Foroohar | SVB Leerink |
Mayank Mamtani | B. Riley Securities |
Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. Throughout today's recorded presentation, all participants will be in a listen-only mode. After the presentation, there will be an opportunity to ask questions. I will now hand the conference call over to Vince Anzalone, Vice President of Investor Relations for Arrowhead. Please go ahead.